Skip to main content

Your search for “Brain Cells” returned 623 results

New Biomarker Predicts Whether Neurons Will Regenerate

October 16, 2023

Researchers from University of California San Diego have identified a new biomarker that can predict whether or not neurons will regenerate after an injury. The findings could help scientists develop regenerative therapies for spinal cord injuries and other neurological conditions.

Stem Cell-derived “Mini-brains” Reveal Potential Drug Treatment for Rare Disorder

September 8, 2015

Using “mini-brains” built with induced pluripotent stem cells derived from patients with a rare, but devastating, neurological disorder, researchers at University of California, San Diego School of Medicine say they have identified a drug candidate that appears to “rescue” dysfunctional cells by suppressing a critical genetic alteration.

Protein Switch Dictates Cellular Fate: Stem Cell or Neuron

February 13, 2014

Researchers at the University of California, San Diego School of Medicine have discovered that a well-known protein has a new function: It acts in a biological circuit to determine whether an immature neural cell remains in a stem-like state or proceeds to become a functional neuron.

UC San Diego Moores Cancer Center Offers New Hope for Deadly Brain Tumor

February 3, 2012

…fighting the meanest, most aggressive, most common kind of brain tumor in the United States: recurrent glioblastoma multiforme (GBM). In the United States, each year, approximately 10,000 patients are affected by GBM. Now, a novel investigational device – available only at clinical trial sites – is offering new hope to…

Southern California’s First Real-Time MRI-Guided Gene Therapy for Brain Cancer

August 6, 2013

Neurosurgeons at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center are among the first in the world to utilize real-time magnetic resonance imaging (MRI) guidance for delivery of gene therapy as a potential treatment for brain tumors.

Enzyme Drives Cognitive Decline in Mice, Provides New Target for Alzheimer’s

November 28, 2022

UC San Diego researchers identify the PKCα enzyme as a promising therapeutic target in Alzheimer’s disease; a mutation that increases its activity led to biochemical, cellular and cognitive impairments in mice.

Epigenetic Driver of Glioblastoma Provides New Therapeutic Target

July 6, 2015

Using human tumor samples and mouse models, researchers at University of California, San Diego School of Medicine and Moores Cancer Center discovered that cancer stem cell properties are determined by epigenetic changes — chemical modifications cells use to control which genes are turned on or off.

CAR-T Immunotherapies May Have a New Player

June 29, 2018

…modified versions of patient’s T-cells to target and kill cancer cells. In a new study, researchers at University of California San Diego School of Medicine and University of Minnesota report that similarly modified natural killer (NK) cells derived from human induced pluripotent stem cells (iPSCs) also displayed heightened activity against…

Iron Buildup in Brain Linked to Higher Risk for Movement Disorders

August 1, 2022

UC San Diego researchers report that individuals with two copies of a gene mutation show evidence of substantial iron buildup in regions of the brain, raising risk for movement disorders like Parkinson’s disease.

New Website to Open World of Neurosciences to Public

March 13, 2012

…Diego’s Kavli Institute for Brain and Mind to Serve as editor in chief Nick Spitzer Which of the following statements are true? We only use 10 percent of our brain. Listening to classical music can make us smarter. Brain damage is permanent. Alcohol kills brain cells. If you’ve said none…

Category navigation with Social links